WASHINGTON — As the health care debate intensifies, the nation’s leading advocacy group for older Americans is ramping up its efforts to influence what goes into the legislation, and spending more to lobby Congress.
“There is no doubt that health care has been the big thing for us this year,” said Jim Dau, a spokesman for AARP. The organization has focused its efforts not just on the debate in Washington but also on lawmakers’ districts around the country, he said.
AARP spent $5.3 million from April 1 through June 30, an increase of $1.2 million over its first-quarter spending of $4 million, according to a CQ MoneyLine analysis of second-quarter lobbying disclosure reports filed Monday with the Senate Office of Public Records.
The filings illustrate how many groups — including senior advocacy groups and industry and labor organizations — are spending more to influence Congress as it barrels toward a decision on overhauling health care.
AARP, a highly visible participant in the contentious debate, has backed a plan by the drug companies to reduce prescription costs by $80 billion over the next decade. The group also has praised the $1 trillion plan developed by three House committees that would provide near-universal health insurance.
However, Dau said the organization has not taken an official position on any government-run insurance plan, a major point of criticism of some Republicans.
With 40 million members and a lobbying team of more than 50 people, AARP is a significant player in Washington.
Second-quarter lobbying reports were due at midnight, and as of early Monday evening, a number of companies and organizations had not filed their reports. But of those that had filed, many — though not all — showed an uptick in spending.
For example, the Business Roundtable, an association of chief executives of large companies, reported second-quarter lobbying expenses of $6.1 million, a $4.9 million increase from the first quarter. As with that of most companies and organizations, that group is interested in influencing the health care bills, and more; its disclosure forms include interest in legislation on taxes, energy, trade, labor and appropriations.
Wal-Mart Stores Inc., a discount chain that has also been active in the health care debate, increased its spending on lobbying to $2.58 million in the second quarter from $1.52 million in the first quarter. Wal-Mart recently broke with many other businesses by endorsing a measure that would require employers to contribute to the cost of employees’ health insurance.
Although it adamantly opposes the Democratic health care bills now being considered in House and Senate committees, the U.S. Chamber of Commerce scaled back its lobbying expenditures — from $9.9 million in the first quarter to $7.4 million in the second quarter.
Other political news of note
Races to watch: Will Obamacare sink Dems in 2014?
Three years after President Barack Obama admitted that his party took a “shellacking” in the midterm elections, Republicans are setting their sights on another political wave in 2014.
- Paul says his economic plan is the only hope for depressed areas such as Detroit
- Mandela biographer says prison ‘crucible’ steeled him and led to victory
- Clinton: Mandela's example 'went way beyond political leadership'
- Obamas to attend memorial service for Mandela
- Races to watch: Will Obamacare sink Dems in 2014?
Some other organizations with an interest in health care also reported reduced lobbying spending from the first quarter to the second quarter. In that category were America’s Health Insurance Plans, from $2 million to $1.8 million; and the American Medical Association, from $4.24 million to $3.98 million. The AMA recently endorsed the House health care plan.
Video: Health care: Obama's "Waterloo"? The pharmaceutical company GlaxoSmithKline spent $2.2 million in the second quarter, up from $1.78 million. Another drugmaker, Eli Lilly, spent $3.5 million on second-quarter lobbying, a jump of $150,000. Johnson & Johnson spent $1.55 million in the second quarter, compared with $1.53 million in the first quarter. Merck & Co. spent $1.53 million from April through June, compared with $1.5 million during the first three months.
Bristol-Myers Squibb, however, spent slightly less, dropping from $814,617 in the first quarter to $809,000 in the second quarter.
The American Beverage Association, which has been fighting proposals to tax sodas to pay for health care, spent $1.2 million on lobbying in the second quarter, up from $140,000 in the first quarter.
The National Association of Children’s Hospitals increased its lobbying tab to $640,000 from $530,000. The American College of Radiology Association spent $1.1 million on lobbying in the second quarter, a slight increase from $923,080.
But the American Dental Association spent $680,000 in the second quarter, a decrease from $830,000, and the American Academy of Family Physicians spent $670,670 in the second quarter, compared with $779,764 in the first three months of the year.
CQ © 2009 All Rights Reserved | Congressional Quarterly Inc. 1255 22nd Street N.W. Washington, D.C. 20037 | 202-419-8500